Published on October 15, 2009 at 6:28 AM
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed shareholder questions about its new laboratory in Las Vegas in an interview of Matthew Schissler, founder and CEO, by analyst Francis Gaskins.
The entire interview is available at http://gaskinsco.com/cbai-10-14-09.mp3
In the interview Mr. Schissler said:
- The Company is now operating day to day operations from its headquarters at the 17,000 square foot facility at 1857 Helm Drive, near the Las Vegas airport.
- The purchase of laboratory equipment has begun and is in process of being set up and readied for validation. The remaining equipment is actively being sourced and expected to be completed by November. The Company expects the first of its cryogenic tanks for storage to begin arriving in December and anticipates a final count of 20-25 tanks to be installed and storing umbilical cord blood stem cells by the end of January. The facility will perhaps be the largest cryogenic storage lab in the U.S.
- The Company expects to hold a grand opening ceremony at the facility, with the date to be announced.
The interview also includes details about the Company's future business strategies and possible business opportunities, which are being evaluated. Mr. Schissler said the new facility will significantly reduce storage costs for Cord Blood America and will allow it to do research and development and to process and store multiple stem cell lines or other medical products.
SOURCE Cord Blood America, Inc.